Clinuvel Pharmaceuticals Limited carries a market capitalization of 353.88M, placing it among publicly traded companies globally.
| Market Cap | 353.88M |
| Enterprise Value | N/A |
Clinuvel Pharmaceuticals Limited's stock has declined approximately -11.02662% over the past 52 weeks. The 50-day moving average sits at 6.90, while the 200-day moving average is 7.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.02662% |
| 50-Day Moving Average | 6.90 |
| 200-Day Moving Average | 7.40 |
| Average Volume (20 Days) | N/A |